Overview
Zheng Chu practices practicing medicine in Beijing, China.
His clinical expertise encompasses Acute Promyelocytic Leukemia and Methicillin-Resistant Staphylococcus Aureus (MRSA).
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Zheng Chu
Is Zheng Chu a top-rated expert for Acute Promyelocytic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Zheng Chu is classified as an Experienced expert for Acute Promyelocytic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Zheng Chu participate in research or clinical trials?
Yes. Zheng Chu has published 14 articles and abstracts on conditions like Acute Promyelocytic Leukemia. You can view a list of Zheng Chu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Promyelocytic LeukemiaMr. Chu isExperienced. Learn about Acute Promyelocytic Leukemia.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)